Immunohistochemical expression of cytosolic phospholipase A2α in non-small cell lung carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 5, 2010, Pages 1367-1372

  Sundarraj, Shenbagamoorthy ^a   Kannan, Soundarapandian ^a  

^a BHARATHIAR UNIVERSITY   (India)

Author keywords

Cytosolic phospholipase A2 Alpha; Immunohistochemistry; Nonsmall cell lung carcinoma

Indexed keywords

EID: 79955954075     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Capper EA, Marshall LA (2001). Mammalian phospholipases A2: mediators of inflammation, proliferation and apoptosis. Prog Lipid Res, 40, 167-97.
2. Dessen A (2000). Structure and mechanism of human cytosolic phospholipase A2. Biochim Biophys Acta, 1488, 40-7.
3. Dong M, Johnson M, Rezaie A, et al (2003). Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis, 24, 307-15.
4. Ghosh M, Tucker DE, Burchett SA, et al (2006). Properties of the group IV phospholipase A2 family. Prog Lipid Res, 45, 487-510.
5. Han C, Demetris AJ, Michalopoulos G, et al (2002). 85- kDa cPLA2 plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am J Physiol Gastrointestinal Liver Physiol, 282, 586-97.
6. Heasley LE, Thaler S, Nicks M, et al (1997). Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer. J Biol Chem, 272, 14501-4.
7. Hefner Y, Borsch-Haubold AG, Murakami M, et al (2000). Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1 related protein kinases. J Biol Chem, 275, 37542-51.
8. Karin M, Lawrence T, Nizet V (2006). Innate immunity gone away: Limking microbial infections to chronic inflammation and cancer. Cell, 124, 823-35.
9. Kawamoto S, Shoji M, Setoguchi Y, et al (1995). Molecular cloning of the 31 kDa cytosolic phospholipase A2, as an antigen recognized by the lung cancer-specific human monoclonal antibody, AE6F4. Cytotechnology, 17, 103-8.
10. Lagorce-Pages C, Paraf F, Wendum D, et al (2004). Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus. Virchows Arch, 444, 426-35.
11. Lee JS, Lippman SM, Benner SE, et al (1994). A randomized placebo controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol, 12, 937-45.
12. Leslie CC (2004). Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol, 82, 1-17.
13. Lin LL, Wartmann M, Lin AY, et al (1993). cPLA2 is phosphorylation and activated by MAP kinase. Cell, 72, 269-78.
14. Miyashita A, Crystal RG, Hay JG (1995). Identification of a 27 bp 52-flanking region element responsible for the low level constitutive expression of the human cytosolic phospholipase A2 gene. Nucleic Acids Res, 23, 293-300.
15. Mountain CF (1997). Revision in the international system for staging lung cancer. Chest, 111, 1710-17.
16. Muthalif MM, Hefner Y, Canaan S, et al (2001). Functional interaction of calcium-/ calmodulin-dependent protein kinase II and cytosolic phospholipase A2. J Biol Chem, 276, 39653-60.
17. Nagase T, Uozumi N, Aoki-Nagase T, et al (2003). A potential inhibitor of cytosolic phospholipase A2, arachidonyl trifluromethyl ketone, attenuates LPS induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol, 284, 720-6.
18. Nagase T, Uozumi N, Ishii S, et al (2000). Acute lung injury by sepsis and acid aspiration: A key role for cytosolic phospholipase A2. Nat Immunol, 1, 42-6.
19. Osterstrom A, Dimberg J, Fransen K, et al (2002). Expression of cytosolic and group X secretary phospholipase A2 genes in human colorectal adenocarcinomas. Cancer Lett, 182, 175-82.
20. Pawliczak R, Han C, Huang X-L, et al (2002). 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferatoractivated receptor gamma activation in human lung epithelial cells. J Biol Chem, 277, 33153-63.
21. Pirianov G, Danielsson C, Carlberg C, et al (1999). Potentiation by vitamin D analogs of TNFα and ceramide induced apoptosis in MCF 7cells is associated with activation of cPLA2. Cell Death Differ, 6, 890-901.
22. Schaloske, Dennis (2006). The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 1761, 1246-59.
23. Schievella AR, Regier MK, Smith WL, et al (1995). Calciummediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J Biol Chem, 270, 30749-54.
24. Song H, Ramanadham S, Bao S, et al (2006). Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2. Biochemistry, 45, 6392-406.
25. Soydan AS, Tavares IA, Weech PK, et al (1996). High molecular weight phospholipase A2 and fatty acid in human colon tumours and associated normal tissue. Eur J Cancer, 32, 1781-7.
26. Soydan AS, Tavares IA, Weech PK, et al (1997). High molecular weight phospholipase A2: its occurrence and quantification in human colon cancer and normal mucosa. Adv Exp Med Biol, 400, 31-7.
27. Sved P, Scott KF, McLeod D, et al (2004). Oncogenic action of secreted phospholipase A2 in prostate cancer. Cancer Res, 64, 6934-40.
28. Uozumi N, Kume K, Nagase T, et al (1997). Role of cytosolic phospholipase A2 in allergic response and parturition. Nature, 390, 618-22.
29. Van Putten V, Refaat Z, Dessev C, et al (2001). Induction of cytosolic phospholipase A2 by oncogenic Ras is mediated through the JNK and ERK pathways in rat epithelial cells. J Biol Chem, 276, 1226-32.
30. Wang XH, Yan GT, Wang LH, et al (2003). The mediating role of cPLA2 in IL-1 ( and IL-6 release in LPS-induced HeLa cells. Cell Biochem Funct, 22, 41-4.
31. Wendum D, Comperat E, Boelle PY, et al (2005). Cytoplasmic phospholipase A2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer. Mod Pathol, 18, 212-20.
32. Wendum D, Svrcek M, Rigau V, et al (2003). COX-2, inflammatory Secreted PLA2 and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol, 16, 130-6.
33. World Health Organization (1981). World health organization histological typing of lung tumors. International histologic classification of tumors, geneva: World health organization, 1981, 1.
34. Wu T, Han C, Lunz 3rd JG, et al (2002). Involvement of 85- kd cytosolic phospholipase A2 and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. Hepatology, 36, 363-73.